chlorhexidine has been researched along with pentoxifylline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Berenson, JR; Epstein, JB; Epstein, MS; Gorsky, M; Wicknick, FW | 1 |
Dhanda, J; Rennie, L; Shaw, R | 1 |
Lim, YBY; Rogers, SN; Willcocks, EJ | 1 |
4 other study(ies) available for chlorhexidine and pentoxifylline
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-Tocopherol; Anti-Infective Agents, Local; Antioxidants; Bone Density Conservation Agents; Chlorhexidine; Diphosphonates; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Mouthwashes; Osteonecrosis; Pentoxifylline; Phosphodiesterase Inhibitors; Treatment Outcome | 2010 |
Current trends in the medical management of osteoradionecrosis using triple therapy.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density Conservation Agents; Chlorhexidine; Clodronic Acid; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Mandibular Diseases; Mouthwashes; Osteoradionecrosis; Pentoxifylline; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiation-Protective Agents; Severity of Illness Index; Tocopherols | 2018 |
Patients' experience and perceived concerns regarding obtaining and taking prescriptions for head and neck osteoradionecrosis.
Topics: Chlorhexidine; Head and Neck Neoplasms; Humans; Osteoradionecrosis; Pentoxifylline; Prescriptions; Tocopherols | 2022 |